Bio-Rad Labs (BIO) Tops Q2 EPS by 58c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $280.05 --0%
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.38, $0.58 better than the analyst estimate of $2.80. Revenue for the quarter came in at $691.1 million versus the consensus estimate of $682.62 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Travere Therapeutics (TVTX) PT Raised to $65 at Guggenheim
- Acuity Brands (AYI) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
